Aptus Capital Advisors, LLCAptus Capital Advisors, LLC

Institutional investor · Portfolio as of Q2 2019

SEC EDGAR SourceSEC Filings

Top Holdings329 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
DRSKDRSK
ETF

APTUS DEFINED RISK ETF

3.5M$96.7M13.6%$21.02+3.36%
2 qtrssince 2019-Q1
Increased
79
FTVAFTVADelisted
ETF

Aptus Fortified Value ETF

2.2M$57.7M8.1%$26.34-1.13%
2 qtrssince 2019-Q1
Increased
62
ADMEADME
ETF

APTUS DRAWDOWN MANAGED EQUITY ETF

1.5M$44.2M6.2%$28.21+3.18%
2 qtrssince 2019-Q1
Increased
64
OSCVOSCV
ETF

OPUS SMALL CAP VALUE ETF

1.1M$28.8M4.0%$22.20+3.82%
2 qtrssince 2019-Q1
Increased
67
SPDWSPDW
ETF

SPDR INDEX SHS FDS

560,626$16.6M2.3%$23.90+2.34%
2 qtrssince 2019-Q1
Increased
64
FTSMFTSM
ETF

FIRST TR EXCHANGE-TRADED FD

270,637$16.3M2.3%$48.87+0.09%
2 qtrssince 2019-Q1
Increased
78
IBDRIBDR
ETF

ISHARES TR

614,129$15.3M2.2%$19.19+3.61%
2 qtrssince 2019-Q1
Increased
57
IBDQIBDQDelisted
ETF

ISHARES

597,695$15.3M2.1%$20.40+3.24%
2 qtrssince 2019-Q1
Increased
57
IBDPIBDPDelisted
ETF

ISHARES

597,411$15.2M2.1%$21.31+2.74%
2 qtrssince 2019-Q1
Increased
57
IBDOIBDODelisted
ETF

ISHARES

594,416$15.1M2.1%$22.21+2.02%
2 qtrssince 2019-Q1
Increased
57
IBDNIBDNDelisted
ETF

ISHARES

596,613$15M2.1%$24.96+1.09%
2 qtrssince 2019-Q1
Increased
57
IBDMIBDMDelisted
ETF

iShares iBonds Dec 2021 Term Co

601,253$15M2.1%$24.75+0.72%
2 qtrssince 2019-Q1
Increased
57
IBDLIBDLDelisted
ETF

iShares iBonds Dec 2020 Term Co

589,757$14.9M2.1%$25.26+0.34%
2 qtrssince 2019-Q1
Increased
57
SPYMSPYM
ETF

SPDR PORTFOLIO S&P 500 ETF

362,617$12.5M1.8%$30.32+3.01%
2 qtrssince 2019-Q1
Increased
60
SPABSPAB
ETF

SPDR SERIES TRUST

386,355$11.3M1.6%$22.86+2.52%
2 qtrssince 2019-Q1
Increased
52
VOOVOO
ETF

VANGUARD S&P 500 ETF

18,822$5.1M0.7%$243.660.00%
1 qtr
New
53
VIGVIG
ETF

VANGUARD DIVIDEND APPRECIATION ETF ETF

41,596$4.8M0.7%$96.75+5.47%
2 qtrssince 2019-Q1
Decreased
0
MINTMINT
ETF

PIMCO ETF TR

40,508$4.1M0.6%$81.56+0.04%
2 qtrssince 2019-Q1
Increased
61
FTCSFTCS
ETF

FIRST TR EXCHANGE-TRADED FD

70,919$4M0.6%$50.34+3.30%
2 qtrssince 2019-Q1
Increased
51

PROCTER & GAMBLE CO/THE

34,240$3.8M0.5%$85.93+6.13%
2 qtrssince 2019-Q1
Decreased
0
$710.7M
AUM
329
Positions
Q2 2019
Filing
Rating · 3.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q2'19
New25%Increased52%Decreased10%Exited13%
Composition
Equity vs derivatives
Equity99%Puts0%Calls1%
Holding period
Avg <1 quarter
<1Q19%1-4Q79%1-2Y0%2Y+2%

Aptus Capital Advisors, LLC manages $710.7M across 329 positions as of Q2 2019. Top holdings: DRSK (13.6%), FTVA (8.1%), ADME (6.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q2 2019 Summary

Active quarter - 62 new positions, 38 exits, 142 increased. Top move: DRSK (INCREASED, conviction 79). Portfolio: $711M across 329 positions.

Top holdings by portfolio weight

Total AUM$704M
DRSK13.61%
FTVA8.12%
ADME6.21%
OSCV4.05%
SPDW2.33%
FTSM2.29%
IBDR2.16%
IBDQ2.15%
IBDP2.14%
IBDO2.12%
Other2.11%

Portfolio allocation by GICS sector

Sectors11
Unknown69.92%
Technology5.85%
Healthcare5.07%
Consumer Cyclical4.45%
Financial Services4.00%
Industrials3.60%
Consumer Defensive2.64%
Energy1.26%
Basic Materials0.96%
Communication Services0.96%
Other1.30%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record62
Conviction39
Concentration40
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ATRATRAPTARGROUP INC
Q3 2024 Q2 2026+32,997 shares+$3.6M
8Q
ACAACAARCOSA INC
Q3 2024 Q2 2026+68,349 shares+$13.9M
8Q
BYDBYDBOYD GAMING CORP
Q3 2024 Q2 2026+62,909 shares+$7.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used